PTGS2 and chronic kidney disease: Multiple lines of evidence imply that cyclooxygenase 2(COX2), its metabolite prostaglandin E2 (PGE2) as well as its receptor EP2 enhance cell growth in SHPT patients with CKD (Zhang et al., 2011; Zhang et al., 2019).